COPD Definition
Characteristized by chronic airflow limitation which is not fully reversible
Includes:
Risk Factors
Cigarette smoking
Asthma (increased airway responsiveness)
Occupational exposures, air pollution (indoor and outdoor), and second hand smoke (less important than smoking)
α1 Antitrypsin Deficiency
GERD
Other associations: age, FHx of COPD, and low SES
Molecular Pathogenesis of COPD
Inflammation
Cell Death–Both cells and matrix disappear leading to airspace enlargement
Ineffective Repair– Limited ability to repair alveolar damage
Pathology of COPD (Large airways, small airways, parenchyma)
Large Airways
Small Airways
Parenchyma
Bellows function
Impaired movement of air due to decreased elastic recoil and support for airways (inc’d resistance)
Obstructive pattern on spirometry
Changes in Lung Volumes in COPD and its Effects
Air trapping because decreased elastic recoil leads to incomplete expiration. This increases residual volume.
Therefore, hyperinflation occurs, increasing the work of breathing as diaphragm flattens
Because of the air trapping, VQ mismatches occur.
Pulmonary HTN occur, which may lead to cor pulmonale and RV failure
Type A vs. Type B
Type A:
Type B:
COPD Recap (Reference)
Diagnosis
**Dyspnea **
Cough
**Sputum Production **
Wheezing and Chest Tightness
Physical Exam
No specific findings, only suggestive
Hyperinflation of chest/barrel chest
Use of accessory muscles, paradoxical lower rib movement, reduced expansion
Pursed lip breathing, prolonged expiration
Distant breath sounds, hyperresonant chest
Signs of cor pulmonale: peripheral edema, elevated JVP, hepatomegaly
Signs of hypoxemia
Cachexia
Ancillary Examinations (tests)
Spirometry to measure airflow obstruction
CXR to r/o other pathologies
Hemoglobin (anemia or polycythemia)
CT if sxs > PFTs
EKG, echo
Oximetry
Differential Diagnosis
Asthma
Bronchiectasis
Obliterative bronchitis
CHF
Upper airway lesions, including LCA
Treatment Goals of COPD
Control sxs
Improve exercise tolerance
Decrease frequency and severity of exacerbations
Management of Stable COPD
Spirometry should be used to screen and diagnose airflow obstruction.
Avoid Risk Factors
Influenza vaccine annually
Pneumococcal polysaccharide vaccine (S. pneumo)
Treat complications
Pulmonary Rehab: improves survival, quality of life (inc’d exercise tolerance, reduces hospitalizations, psychosocial benefit, benefits extend beyond period of training)
Changes in quality of life
Depression due to changes in exercise tolerance, difficulty with “just trying to breathe,” etc.
Social isolation as activity becomes more difficult, oxygen apparatus limits movements, etc.
Oxygen therapy in COPD
Improves survival in pts with severe hypoxemia when used >15hrs/day
Acute Exacerbations of COPD
Increased dyspnea (at rest), heart rate (>110), cough, or sputum production
Increased ventilatory rate (>25)
Hypoxemia (cyanosis)
Fever
Change in sputum color or character
New use fo accessory muscles
Development or increase in wheezing
Peripheral edema
Change in mental status
Fatigue
Decrease in peak flow or FEV1
Chest tightness
BOLD = SEVERE EXACERBATION
Tests in Acute Exacerbation of COPD
Hx: Focus on previous exacerbations, triggers, changes in meds
PE: identifying signs of exacerbation (vital signs, oxygen saturation, etc.)
CXR if pneumonia is suspected, CBC (infection)
ABG if O2 sat <88%. If pH <7.32, admit because risk of respiratory failure
CT, BNP, echo, EKG if HF suspected and dx unclear
Spontaneous ___________ can occur in moderate to severe COPD
pneumothorax
Up to 50% will experience a second if pleurodesis is not performed after first one